Novo Nordisk Stock Forecast - 4 Period Moving Average
| NVO Stock | USD 106.80 0.67 0.63% |
The 4 Period Moving Average forecasted value of Novo Nordisk AS on the next trading day is expected to be 106.47 with a mean absolute deviation of 2.30 and the sum of the absolute errors of 131.16. Novo Stock Forecast is based on your current time horizon. Although Novo Nordisk's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Novo Nordisk's systematic risk associated with finding meaningful patterns of Novo Nordisk fundamentals over time.
Novo |
Novo Nordisk 4 Period Moving Average Price Forecast For the 2nd of December
Given 90 days horizon, the 4 Period Moving Average forecasted value of Novo Nordisk AS on the next trading day is expected to be 106.47 with a mean absolute deviation of 2.30, mean absolute percentage error of 8.45, and the sum of the absolute errors of 131.16.Please note that although there have been many attempts to predict Novo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Novo Nordisk's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Novo Nordisk Stock Forecast Pattern
| Backtest Novo Nordisk | Novo Nordisk Price Prediction | Buy or Sell Advice |
Novo Nordisk Forecasted Value
In the context of forecasting Novo Nordisk's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Novo Nordisk's downside and upside margins for the forecasting period are 104.68 and 108.25, respectively. We have considered Novo Nordisk's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Novo Nordisk stock data series using in forecasting. Note that when a statistical model is used to represent Novo Nordisk stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.8935 |
| Bias | Arithmetic mean of the errors | 1.137 |
| MAD | Mean absolute deviation | 2.301 |
| MAPE | Mean absolute percentage error | 0.0198 |
| SAE | Sum of the absolute errors | 131.1575 |
Predictive Modules for Novo Nordisk
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novo Nordisk AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novo Nordisk's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Novo Nordisk
For every potential investor in Novo, whether a beginner or expert, Novo Nordisk's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Novo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Novo. Basic forecasting techniques help filter out the noise by identifying Novo Nordisk's price trends.View Novo Nordisk Related Equities
| Risk & Return | Correlation |
Novo Nordisk AS Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Novo Nordisk's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Novo Nordisk's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Novo Nordisk Market Strength Events
Market strength indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk stock market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns.
Novo Nordisk Risk Indicators
The analysis of Novo Nordisk's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Novo Nordisk's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting novo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.38 | |||
| Standard Deviation | 1.81 | |||
| Variance | 3.29 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Novo Nordisk
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novo Nordisk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will appreciate offsetting losses from the drop in the long position's value.Moving together with Novo Stock
| 0.78 | HLN | Haleon plc | PairCorr |
| 0.87 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.75 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.81 | ANRO | Alto Neuroscience, | PairCorr |
Moving against Novo Stock
| 0.84 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.75 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.72 | FNMFO | Federal National Mortgage | PairCorr |
| 0.61 | KB | KB Financial Group | PairCorr |
| 0.5 | ITCL | Banco Ita Chile | PairCorr |
The ability to find closely correlated positions to Novo Nordisk could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novo Nordisk when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novo Nordisk - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novo Nordisk AS to buy it.
The correlation of Novo Nordisk is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novo Nordisk moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novo Nordisk AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novo Nordisk can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Novo Nordisk to cross-verify your projections. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.224 | Dividend Share 9.9 | Earnings Share 2.99 | Revenue Per Share 60.698 | Quarterly Revenue Growth 0.214 |
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.